BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29140542)

  • 1. Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
    Starlinger P; Pereyra D; Haegele S; Braeuer P; Oehlberger L; Primavesi F; Kohler A; Offensperger F; Reiberger T; Ferlitsch A; Messner B; Beldi G; Staettner S; Brostjan C; Gruenberger T
    Hepatology; 2018 Apr; 67(4):1516-1530. PubMed ID: 29140542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study.
    Aryal B; Yamakuchi M; Shimizu T; Kadono J; Furoi A; Gejima K; Takenouchi K; Komokata T; Hashiguchi T; Imoto Y
    Cancer Biomark; 2019; 26(1):51-61. PubMed ID: 31322547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated ADAMTS13 Activity is Associated with Poor Postoperative Outcome in Patients Undergoing Liver Resection.
    Haegele S; Fuxsteiner J; Pereyra D; Koeditz C; Rumpf B; Schuetz C; Schwarz C; Brostjan C; Gruenberger T; Starlinger P
    Sci Rep; 2018 Nov; 8(1):16823. PubMed ID: 30429491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.
    Schwarz C; Fitschek F; Mittlböck M; Saukel V; Bota S; Ferlitsch M; Ferlitsch A; Bodingbauer M; Kaczirek K
    Gut Liver; 2020 Mar; 14(2):218-224. PubMed ID: 30428508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans.
    Starlinger P; Assinger A; Haegele S; Wanek D; Zikeli S; Schauer D; Birner P; Fleischmann E; Gruenberger B; Brostjan C; Gruenberger T
    Hepatology; 2014 Jul; 60(1):257-66. PubMed ID: 24277679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of von Willebrand factor in adult patients with congenital heart disease.
    Ohuchi H; Hayama Y; Miike H; Suzuki D; Nakajima K; Iwasa T; Konagai N; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki KI; Nakai M
    Heart; 2020 Jun; 106(12):910-915. PubMed ID: 32188625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
    Prasanna KS; Goel A; Amirtharaj GJ; Ramachandran A; Balasubramanian KA; Mackie I; Zachariah U; Sajith KG; Elias E; Eapen CE
    Indian J Gastroenterol; 2016 Nov; 35(6):432-440. PubMed ID: 27822882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction.
    Starlinger P; Haegele S; Wanek D; Zikeli S; Schauer D; Alidzanovic L; Fleischmann E; Gruenberger B; Gruenberger T; Brostjan C
    Br J Surg; 2015 Jun; 102(7):826-36. PubMed ID: 25871570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient von Willebrand factor-mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice.
    Kirschbaum M; Jenne CN; Veldhuis ZJ; Sjollema KA; Lenting PJ; Giepmans BNG; Porte RJ; Kubes P; Denis CV; Lisman T
    Liver Int; 2017 Nov; 37(11):1731-1737. PubMed ID: 28178387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rodenticidal hepatotoxicity: Raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol.
    Sardar D; Mathews N; Mammen J; Nair SC; Jacob S; Patel L; Thomas A; Jhanwar S; Sharma A; Sen M; Vijayalekshmi B; Balasubramanian KA; Subramani K; Thomas L; Abhilash KPP; Zachariah U; Elias E; Goel A; Eapen CE
    Indian J Gastroenterol; 2019 Dec; 38(6):527-533. PubMed ID: 32077040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.